Immunic regains compliance with Nasdaq minimum bid price requirement

* Immunic (IMUX [https://seekingalpha.com/symbol/IMUX]) on Wednesday said it has received written notice from Nasdaq, informing that it has regained compliance with the minimum bid price requirement as the closing bid price of the company's common stock was at $1.00 per share or greater for at least 20 consecutive business days, satisfying the Nasdaq requirement on March 26, 2026. 
* IMUX +5.4% premarket to $1.17.
* Source: Press Release [https://seekingalpha.com/pr/20458618-immunic-regains-compliance-with-nasdaq-minimum-bid-price-requirement]

MORE ON IMMUNIC

* Immunic garners new Buy at Guggenheim on lead asset [https://seekingalpha.com/news/4567957-immunic-stock-gains-new-buy-guggenheim]
* Immunic rises after $400M private placement, leadership transition [https://seekingalpha.com/news/4551908-immunic-announces-private-placement-ceo-change]
* Seeking Alpha’s Quant Rating on Immunic [https://seekingalpha.com/symbol/IMUX/ratings/quant-ratings]
* Historical earnings data for Immunic [https://seekingalpha.com/symbol/IMUX/earnings]
* Financial information for Immunic [https://seekingalpha.com/symbol/IMUX/income-statement]